facebook pixel
chevron_right Business
transparent transparent
Centre bans 328 combination drugs in setback for pharma companies
It said it was prohibiting the manufacture for sale, sale or distribution for human use of the 328 FDCs with immediate effect. Combination drugs are used to improve patients' compliance, as it is easier to get patients to take one drug rather than several. Companies such as Indian unit of Abbott Laboratories had filed court appeals against the government's 2016 order. Abbott did not respond to a request for comment and it was not immediately clear how the ban would impact it.
For the best experience use Awesummly app on your Android phone
Awesummly Chrome Extension Awesummly Android App